"*Nationwide studies refer to those offered in every US State." The Rituximab Study (TrialNet)Who can participate?This study is no longer recruiting patients. People were eligible for this study if they:What is this study? The goal of the study is to find out if the medicine rituximab can prevent further insulin-producing beta cell destruction. Rituximab has been successfully used in other illnesses to slow down the immune response.Why is it being done? TrialNet researchers hope that rituximab will help to scale down the attack on beta cells and allow them to keep making insulin. Even if rituximab works, patients will still need to take insulin but your blood sugar (glucose) should be easier to control. With your blood sugar controlled better, you'll have less chance of developing: (a) severe hypoglycemia (low blood sugar), and (b) possible long-term problems of diabetes such as blindness, kidney failure, nerve damage, heart attack, and stroke.If I enroll in this study, what do I have to do? If you decide to be in the study, you will be randomly (by chance) assigned to receive rituximab or receive a placebo (a pretend medicine that does nothing). The group you are assigned to is decided by chance (as by the toss of a coin or drawing straws). Neither you nor your doctor will be able to choose which group you are in. Also, neither you nor the researchers will know which group you are in.Can I participate in other studies if I participate in this one? You can’t participate in any other research studies in which treatments are given. However, it might be possible for you to participate in other kinds of studies.How can I learn more? Please call the toll free number below or visit the TrialNet website for more information.
*Nationwide studies refer to those offered in every US State. |